Sentia Medical Sciences

Sentia Medical Sciences Inc. is poised to become a world leader in developing novel peptide therapies for managing and treating stress-related disorders, with a drug called Stressin that blocks the action of corticotropin-releasing factor (CRF) and urea, the primary mediators of the body's response to stress.